Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 23, 2011

View Archived Issues

Pfizer describes identification of new drug for allergic rhinitis

VANTAGE 88 reveals activity of combination therapy for multiple myeloma

Biomarkers of kidney injury identified in patients with MM

Galectin Therapeutics reviews recent progress

AstraZeneca provides update on olaparib and TC-5214 programs

U.K. study uncovers new biomarker for bronchiolitis obliterans syndrome

Kissei presents new nonpurine adenosine A2A receptor antagonists

GSK begins phase IIa trial of GSK-2586881

DiaMedica's humanized MAb for type 2 diabetes shows improved binding affinity

Merck & Co. discloses new B-raf inhibitors

Novel GPR119 receptor agonists discovered in Japan

GlaxoSmithKline presents novel protein kinase inhibitors

New 11-beta-HSD1 inhibitors developed in Korea

Novel somatostatin sst5 receptor antagonists synthesized

ALS Therapy Development Institute collaborates with Biogen Idec and UCB

Topline phase III data presented on teriflunomide in MS

FDA issues update on Multaq review

Repligen completes acquisition

Clinuvel reports final data from phase III afamelanotide trial

Affibody and Nuclisome join forces to develop cancer therapeutics

TiGenix clear to begin phase I study of stem cell product

EMA validates MAA for single-tablet HIV-1 therapy

Galaczym obtains new orphan drug status

Salix Pharmaceuticals acquires Oceana Therapeutics

ImmunoGen and Lilly enter collaboration for antibody-based anticancer therapeutics

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...